Last reviewed · How we verify

NCT05408260

A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer

Completed NA Last updated 5 January 2026
What this trial tests

NA trial testing Ultrasonography in Malignant Breast Neoplasm in 12 participants. Completed in 17 February 2025.

Timeline
18 November 2022
Primary endpoint
17 February 2025
17 February 2025

Quick facts

Lead sponsorThomas Jefferson University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment12
Start date18 November 2022
Primary completion17 February 2025
Estimated completion17 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

18 and older, female only, with Malignant Breast Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial evaluates automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) for the screening of women who have undergone breast reconstruction after breast cancer. Ultrasounds use high-frequency sound waves to create pictures of internal organs and tissues. ABUS has been found to be equal to HHUS for whole breast screening, but no data exist on its use for screening of reconstructed patients. This clinical trial evaluates the feasibility of using ABUS versus HHUS to screen women who have undergone reconstruction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasonography

Trials testing the same drug.

Other recruiting trials for Malignant Breast Neoplasm

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05408260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing